Coeptis Therapeutics Inc. Quarterly Selling and Marketing Expense in USD from Q1 2020 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Coeptis Therapeutics Inc. quarterly/annual Selling and Marketing Expense history and growth rate from Q1 2020 to Q3 2022.
  • Coeptis Therapeutics Inc. Selling and Marketing Expense for the quarter ending September 30, 2022 was $2.86K.
  • Coeptis Therapeutics Inc. Selling and Marketing Expense for the twelve months ending September 30, 2022 was $6.91K, a 27.5% decline year-over-year.
  • Coeptis Therapeutics Inc. annual Selling and Marketing Expense for 2021 was $2.92K, a 55.8% decline from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $6.91K $2.86K +$2.86K Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $4.05K $4.05K +$4.05K Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $0 $0 -$2.92K -100% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $2.92K $0 -$6.61K -100% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-11
Q3 2021 $9.53K $0 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $9.53K $0 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $9.53K $2.92K +$2.92K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $6.61K $6.61K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $0 Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $0 Jan 1, 2020 Mar 31, 2020 10-Q/A 2021-05-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.